Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0001179110-16-027221
Filing Date
2016-07-01
Accepted
2016-07-01 16:27:06
Documents
1
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 3/A - edgar.html 3/A  
1 FORM 3/A - edgar.xml 3/A 2291
  Complete submission text file 0001179110-16-027221.txt   3812
Mailing Address 375 PHEASANT RUN NEWTOWN PA 18940
Business Address 375 PHEASANT RUN NEWTOWN PA 18940 267-759-3681
Onconova Therapeutics, Inc. (Issuer) CIK: 0001130598 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SICOR INC 19 HUGHES IRVINE CA 92618-1902
Business Address
STOVER JACK E (Reporting) CIK: 0001203603 (see all company filings)

Type: 3/A | Act: 34 | File No.: 001-36020 | Film No.: 161747254